ESR1 and breast cancer: The pituitary hormone prolactin (PRL) is essential for proliferative expansion of normal differentiated breast epithelial cells (16), promotes malignant ER+ mammary tumors in rodents (17–20), and is a risk factor for ER+ breast cancer in women (17, 18, 21–23).